Therefore, the processes elicited in our cytokine-stimulated hCSs may well mimic the neuroinflammatory response in the brains of neurological disease patients, in particular during MS pathogenesis, and the identification of their molecular signatures contributes to the development of TNFα-, IL-1β- and NFκB-directed therapies. The gene discussed is IL1B; the disease is nervous system disorder.